Charmaine Lykins
Keine laufenden Positionen mehr
Profil
Charmaine Lykins served as Vice President of Marketing at Lundbeck Pharmaceuticals Ltd.
from 2013 to 2018 and at ACADIA Pharmaceuticals, Inc. from 2018 to 2019.
She will serve as Chief Commercial Officer at Karuna Therapeutics, Inc. from 2021 to 2023.
Lykins earned an undergraduate degree from Ball State University in 1993 and an MBA from Darla Moore School of Business in 2000.
Ehemalige bekannte Positionen von Charmaine Lykins
| Unternehmen | Position | Ende |
|---|---|---|
| KARA THER | Corporate Officer/Principal | 05.01.2023 |
| Lundbeck Pharmaceuticals Ltd. | Sales & Marketing | 01.02.2018 |
| ACADIA PHARMACEUTICALS INC. | Sales & Marketing | - |
Ausbildung von Charmaine Lykins
| Ball State University (Indiana) | Undergraduate Degree |
| Darla Moore School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Lundbeck Pharmaceuticals Ltd. | |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
